down arrow

Ningxia Zhongke Biotechnology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE000000W47
CNY
3.98
-0.75 (-15.86%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Ningxia Zhongke Biotechnology Co., Ltd.
Why is Ningxia Zhongke Biotechnology Co., Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 15.46% and Operating profit at -230.09% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 89.76%, its profits have risen by 59.4%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ningxia Zhongke Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Ningxia Zhongke Biotechnology Co., Ltd.
-100.0%
3.68
48.34%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.46%
EBIT Growth (5y)
-230.09%
EBIT to Interest (avg)
-2.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
32.15
Sales to Capital Employed (avg)
0.42
Tax Ratio
0.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-26.51
EV to EBIT
-9.47
EV to EBITDA
-14.43
EV to Capital Employed
4.44
EV to Sales
8.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-46.94%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
NET PROFIT(HY)

Higher at CNY -171 MM

ROCE(HY)

Highest at 0%

DEBT-EQUITY RATIO (HY)

Lowest at -899.95 %

NET SALES(Q)

At CNY 119.21 MM has Grown at 26.67%

-6What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY -263.37 MM

INTEREST(Q)

At CNY 9.65 MM has Grown at 182.33%

RAW MATERIAL COST(Y)

Grown by 6.47% (YoY

Here's what is working for Ningxia Zhongke Biotechnology Co., Ltd.
Net Profit
Higher at CNY -171 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Profit
At CNY -171 MM has Grown at 59.76%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Sales
At CNY 119.21 MM has Grown at 26.67%
over average net sales of the previous four periods of CNY 94.11 MM
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio
Lowest at -899.95 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Ningxia Zhongke Biotechnology Co., Ltd.
Interest
At CNY 9.65 MM has Grown at 182.33%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY -263.37 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Raw Material Cost
Grown by 6.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."